News › Clinical Practice, Industry News, Patient Care

Galderma Receives FDA Approval for Restylane Kysse

May 5, 2020

Galderma has announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology, globally referred to as the Optimal Balance Technology. Restylane Kysse is proven to last for up to one year with high levels of patient satisfaction for people with lips that have changed due to the aging process or for those seeking natural-looking, fuller lips.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
    • Allergan Aesthetics Receives Approval for Boey® (trenibotulinumtoxinE) in Canada
    • SafeLink Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel